Document:

EX-10.1

 Exhibit 10.1 

FORM OF INCENTIVE BONUS AGREEMENT 

This Incentive Bonus Agreement (this “Agreement”) between Savient Pharmaceuticals, Inc. (the “Company”), and
[                    ] (“Employee”) is made and entered into effective as of the date the Employee executes this Agreement as set
forth below (the “Effective Date”). 
 RECITALS 

A. Employee occupies a key position with the Company. In order to ensure the continued effective conduct of the Company’s business, the
Company will require the continuous services of Employee as the Company explores alternatives for maximizing the Company’s value. 
 B.
The Company desires to offer Employee an incentive bonus to incentivize Employee throughout the transition process. 
 NOW, THEREFORE, in
consideration of the mutual covenants and agreements contained herein, and with reference to the above recitals, the parties hereby agree as follows: 

1. Definitions. For purposes of this Agreement: 

(a) “Board” shall mean the Company’s Board of Directors. 

(b) “Cause” shall exist where, in the Company’s sole reasonable discretion, the Company determines that
(i) Employee has been insubordinate or refused or failed to carry out the instructions of the Company or the Board relating to the Company’s business and strategic plans for the Company; (ii) Employee has engaged in misconduct or
negligence in performing Employee’s duties and responsibilities; (iii) Employee has engaged in conduct which is dishonest, criminal, fraudulent, or otherwise involves moral turpitude, or which is materially injurious to the Company; and/or
(iv) Employee has engaged in activity prohibited by any other agreement between Employee and the Company. For the avoidance of doubt, this definition of Cause shall apply only to this Agreement and shall have no effect on any other agreement,
plan or policy of the Company that may apply to the Employee and the definition of “cause” contained in such agreement, plan or policy shall control. 

(c) “Incentive Bonus” shall mean a cash award as described in Section 2 hereof. 

(d) “Net Incentive Bonus” shall mean the Incentive Bonus after reduction for applicable withholding taxes and other
deductions. 

 (e) “Transaction” shall mean the first to occur of the following: (i) a
transaction or series of transactions pursuant to which any Person acquires, directly or indirectly, securities of the Company (not including the securities beneficially owned by such Person or any securities acquired directly from the Company or
any affiliate thereof) representing 50% or more of the combined voting power of the Company’s then outstanding securities; (ii) a merger, amalgamation or consolidation of the Company with any other corporation, other than a merger,
amalgamation or consolidation which results in the voting securities of the Company outstanding immediately prior to such merger, amalgamation or consolidation continuing to represent (either by remaining outstanding or by being converted into
voting securities of the surviving entity or any parent thereof) at least 50% of the combined voting power of the securities of the Company or such surviving entity or any parent thereof outstanding immediately after such merger, amalgamation or
consolidation; (iii) the sale or disposition by the Company of all or substantially all of the Company’s assets (whether or not pursuant to Chapter 11 of Title 11 of the United States Code), other than a sale or disposition by the Company
of all or substantially all of the Company’s assets to an entity, at least fifty percent (50%) of the combined voting power of the voting securities of which are owned by shareholders of the Company following the completion of such
transaction in substantially the same proportions as their ownership of the Company immediately prior to such sale; or (iv) a restructuring, reorganization (whether or not pursuant to Chapter 11 of Title 11 of the United States Code) and/or
recapitalization of all or substantially all of the Company’s outstanding indebtedness (including bank debt, bond debt, and other on and off balance sheet indebtedness), trade claims, leases (both on and off balance sheet) or other liabilities.
For purposes of this Section 1(d),”Person” shall have the meaning given in Section 3(a)(9) of the Exchange Act of 1934, as modified and used in Sections 13(d) and 14(d) thereof, except that such term shall not include
(i) the Company or any subsidiary thereof, (ii) a trustee or other fiduciary holding securities under an employee benefit plan of the Company or any subsidiary thereof, (iii) an underwriter temporarily holding securities pursuant to
an offering of such securities, or (iv) a corporation owned, directly or indirectly, by the shareholders of the Company in substantially the same proportions as their ownership of shares of the Company. 

2. Incentive Bonus. 
 (a)
Payment of the Incentive Bonus. The Company shall pay to Employee an Incentive Bonus, in a lump sum payment, in an amount equal to [    ]. The Incentive Bonus shall be paid to Employee on such date as shall be
determined by the Board in its sole discretion on or about the time at which the Board determines an approach for addressing the Company’s strategic alternatives. 

(b) Repayment of the Incentive Bonus. The Employee will be required to repay to the Company the Net Incentive Bonus, to
the extent previously paid to Employee in accordance with Section 2(a), in the event (i) the Employee’s employment with the Company terminates for any reason prior to a Transaction (other than a termination by the Company without
Cause or due to the Employee’s death) in which case Employee shall make such repayment no later than thirty (30) days following the 

  
 2 

 
Employee’s termination of employment, or (ii) a Transaction has not occurred by April 1, 2014 in which case Employee shall make such repayment no later than May 1, 2014 (each,
a “Repayment Trigger”). If the Repayment Trigger occurs in 2014 (except in the case of a termination of employment by the Company for Cause), the Net Incentive Bonus to be repaid shall be reduced by the amount of taxes paid by
Employee in respect of the Incentive Bonuses, if any, that Employee is unable to recover plus any additional amount required to put Employee in the same after-tax position as if the Incentive Bonus had not been paid, provided that Employee submits
documentation in a form reasonably acceptable to the Company supporting that Employee is unable to recover such taxes. 
 3.
Withholding. The Incentive Bonus payable to Employee shall be reported as income on the Employee’s Form W-2 for the 2013 fiscal year and shall be subject to applicable taxes and withholding. 

4. Effect on Severance and Other Benefits. This Agreement shall not affect Employee’s eligibility or entitlement to receive any
benefits payable to Employee under any severance, change of control or similar plan, policy or agreement with the Company, however, any severance amount payable to Employee shall be decreased dollar for dollar by an amount equal to the Incentive
Bonus. 
 5. Other Rights and Agreements. This Agreement does not create any employment rights not specifically set forth herein with
respect to Employee. An Employee’s employment remains at-will and can be terminated by the Company at any time and for any reason, with or without cause. This Agreement contains the entire understanding of the Company and Employee with respect
to the subject matter hereof. 
 6. Confidentiality. Employee agrees that the matters described in this Agreement are highly
confidential. Accordingly, except as required by applicable law, Employee agrees and covenants that he will not disclose, reveal, publish, disseminate, or discuss, directly or indirectly, to or with any other person or entity the terms of this
Agreement other than his immediate family, his lawyer and his tax advisor and that any such disclosure, revelation, publication, dissemination or discussion shall result in the immediate forfeiture of the entire Incentive Bonus. 

7. Amendment. This Agreement may be amended or revised only by written agreement signed by an authorized officer of the Company and
Employee. 
 8. Binding Effect. This Agreement shall be binding on the Employee, his executor, administrator and heirs, but may not
be assigned by him. This Agreement may be transferred or assigned by the Company and shall be binding on the transferee or assignee. This Agreement shall automatically be transferred or assigned to and be binding upon any successor in interest to
the Company, whether by merger, consolidation, sale of stock, sale of assets or otherwise. 

  
 3 

 9. Applicable Law. This Agreement shall be construed and enforced in accordance with the
laws of the State of Delaware, without giving effect to the principles of conflict of laws thereof. 
 10. Section 409A. The
Company intends that the Incentive Bonus is not compensation paid under a “nonqualified deferred compensation plan” within the meaning of section 409A of the Internal Revenue Code of 1986, as amended, (“Section 409A”), and
this Agreement shall be interpreted, construed and administered in a manner that reflects this intention. 
 [Signature page follows] 

  
 4 

 IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first above written.

  

			
	SAVIENT PHARMACEUTICALS, INC.
		
	By:	 	  

		 	[Name]
		 	[Title]

  

					
	EMPLOYEE
	
	  

	 [Name]

			
	Date:EX-10.1

 Exhibit 10.1 
  

 
 October 7, 2013 

Mr. Lex Gemas 
 Dear Lex: 

On behalf of dELiA*s, Inc. (the “Company”), I am very pleased to provide you with the proposed terms and conditions of the
Company’s offer to employ you. Tracy has spoken very highly of you and we are all excited about the prospect of you joining the Company. We look forward to a mutually beneficial relationship. 

1. Position: Your initial position will be as the Chief Operating Officer, working out of the Company’s office located at 50 West 23rd Street, New York, NY, 10010. As the Company’s employee, we expect you to devote your full time and energies to the business and affairs of the Company, and to perform any and all duties and
responsibilities associated with this position and as may be reasonably assigned to you from time to time by the Company. Your performance will be reviewed on a periodic basis as long as you remain employed by the Company. 

2. Starting Date/Nature of Relationship: If you accept this offer, your employment with the Company shall commence no later than October 9, 2013.
Except as expressly set forth herein, this letter does not create an employment contract or other agreement and is not a promise of employment for a specific period of time. You understand your employment is at-will and either party may terminate
the relationship with or without cause at any time. 
 3. Compensation and Benefits: Your initial base pay shall be $250,000 per annum, ($9,615.38 on
a bi-weekly basis, every other Friday). You are also eligible to participate in the 2013 Management Incentive Plan (MIP). Your target bonus under this plan will be 75%. Currently, the MIP is based on the company meeting or exceeding planned EBITDA
and individual performance and you have the opportunity to earn up to 200% of your target. Any earned bonus for the 2013 fiscal year will be prorated. Under current company policy, salaries are reviewed annually at the start of each fiscal year.
Your first salary review will be prorated in the spring of 2014. 
 In addition, you will receive options to purchase 300,000 shares of
Common Stock of dELiA*s, Inc., par value $0.01 per share, pursuant to one of dELiA*s stock plans. Such options shall be exercisable at a purchase price per share equal to the closing price of dELiA*s Common Stock, on the NASDAQ market, on the
business day of your commencement of employment with the Company. These options shall vest in equal monthly installments over a 48 month period of time beginning with the first month following your commencement date. Therefore, 6,250 options will
vest each month beginning with the first tranche vesting on November 9, 2013. These options shall expire ten years from the date of grant. 

You will also receive a Restricted Stock grant of 300,000 shares of the Company’s Common Stock, with restrictions that will lapse in
equal monthly installments 

 

 
  

 
over a 36 month period of time beginning with the first lapse of 8,333 occurring on November 9, 2013; provided, however, in the 36th
month, the restrictions on the remaining 8,345 shares shall lapse. You will have the option to pay any applicable required withholding taxes on the lapse of restrictions on restricted shares by electing to have the Company withhold shares where the
restrictions have lapsed. 
 In addition to your compensation, you will be entitled to receive the various benefits (Ex. Comprehensive
Health Benefits, Employee Discounts, 401k, etc.) offered by the Company to its employees. Benefits offered may be modified or changed from time to time at the discretion of the Company. Where a particular benefit is subject to a formal plan,
eligibility to participate in and receive any particular benefit of the plan is governed solely by the applicable plan document, prorated based on date of hire. You would currently be eligible for four (4) weeks paid vacation as well as 9-10
company holiday’s (depending on the calendar), five (5) sick days and three (3) personal days in accordance with company policy. Should you ever have any questions, you should ask David Diamond, SVP of Human Resources, for a copy of
the applicable plan document. 
 4. Severance: If the Company terminates you for any reason other than “Cause” (defined as dishonesty,
substantial malfeasance or non-feasance of duty, unauthorized disclosure of confidential information and conduct substantially prejudicial to the business of the Company or an Affiliate), and provided an Agreement and General Release is executed,
you shall be entitled to the following: a) salary continuation pay for a period of 12 months (the “Severance Period”) of base salary, payable in bi-weekly installments commencing with the bi-weekly pay period immediately after such
termination; b) payment of any earned incentive award under the Management Incentive Plan (MIP) for the fiscal year during which the termination occurs prorated for the portion of the fiscal year during which termination occurs; c) all previously
vested stock options and any unvested stock options that would have vest during the Severance Period will accelerate and vest, and all restricted shares where restrictions have not lapsed as of the date of termination shall be cancelled; and d)
continued participation in all medical and dental plans at the same benefit level your were participating in prior to termination through the Severance Period, which medical benefits will be provided through COBRA. 

5. Change in Control: In the event there is a change of control followed by your termination without Cause within one (1) year following the
change of control, you will receive the severance benefits noted above with the following exception: all unvested options shall vest immediately and all restrictions on all shares of restricted stock where restrictions have not lapsed shall
accelerate and lapse as of the date of termination. 
 6. Non-competition: 

(a) During the Restriction Period (as defined in Section 6(b) below) and in consideration for any payments pursuant to Sections 4 and 5,
the Executive shall not engage in Competition with the Company or any Subsidiary. “Competition” shall mean engaging in any activity, except as provided below, for a Competitor of the Company or any Subsidiary, whether as an employee,
consultant, principal, agent, officer, director, partner, shareholder (except as a less than one percent shareholder of a publicly traded company) or otherwise. A “Competitor” shall mean the entities listed on

 

 
  

 
Exhibit A below. Notwithstanding the foregoing to the contrary, Company may add entities or businesses to Exhibit A which Company in its reasonable business judgment deems to be a competitor,
upon Executive’s prior written consent, such consent not to be unreasonably withheld. If the Executive commences employment or becomes a consultant, principal, agent, officer, director, partner, or shareholder of any entity that is not a
Competitor at the time the Executive initially becomes employed or becomes a consultant, principal, agent, officer, director, partner, or shareholder of the entity, future activities of such entity shall not result in a violation of this provision
unless (1) such activities were contemplated at the time the Executive initially became employed or becomes a consultant, principal, agent, officer, director, partner, or shareholder of the entity (and the contemplation of such activities was
known to the Executive) or (2) the Executive commences directly or indirectly overseeing or managing the activities which are competitive with the activities of the Company or Subsidiary. 

(b) For the purposes of this Section 6 and Section 7 below, “Restriction Period” shall mean the period beginning with the
Commencement Date and ending with the first anniversary of Executive’s termination of employment with the Company, whether voluntary or involuntary. 

7. Non-solicitation 
 (a)
Employees. During the Restriction Period, Executive shall not induce and/or solicit employees of the Company or any Subsidiary to terminate their employment. During the portion of the Restriction Period following the termination of the
Executive’s employment, the Executive shall not directly or indirectly hire any employee of the Company or any Subsidiary or any person who was employed by the Company or any Subsidiary within 180 days of such hiring. 

(b) Vendors/Business Partners. Executive promises and agrees that during the Restriction Period, Executive will not influence or
attempt to influence vendors, or business partners of the Company or any of its present or future subsidiaries, either directly or indirectly, to divert from the Company their business to any individual, partnership, firm, corporation or other
entity then in competition with the business of the Company or any subsidiary or the Company. 
 8. Assignment: The Company reserves the right
at any time to assign this offer letter to any parent, subsidiary or affiliate of the Company now in existence or formed hereafter.  
 9.
Miscellaneous: This letter constitutes our entire offer regarding the terms and conditions of your employment by the Company. It supersedes any prior agreements, or other promises or statements (whether oral or written) regarding the offered
terms of employment. The terms of your employment shall be governed by the law of the State of New York, without giving effect to its principles of conflicts of laws. By accepting this offer of employment, you expressly agree that any action,
demand, claim or counterclaim concerning any aspect of your employment relationship with the Company shall be resolved by a judge alone, and you waive and forever renounce your right to a trial before a civil jury. The Company reserves the right
to alter any of the terms of employment set forth in this letter as needed. 

 

 
  

 You may accept this offer of employment and the terms and conditions hereof by signing a copy
of this letter, which execution will evidence your agreement with the terms and conditions set forth herein and therein. 
 I am happy to
offer you the opportunity to join our Company and we look forward to you joining us! 
 Exhibit A 

Aeropostale, Inc. 

Abercrombie & Fitch, Co. 

American Eagle Outfitters, Inc. 

Wet Seal, Inc. 
 Hot Topic, Inc.

 The Buckle, Inc. 
 Forever 21

 Garage 
 Love Culture 

Rue 21 
 Body Central 

All subsidiaries, divisions, affiliates and successors of the above-named entities are included provided that they primarily engage in the
marketing or sale of specialty apparel, clothing and accessories to girls between the ages of 12 and 18. 
  

			
	By:	 	 /s/ David Diamond

		 	David Diamond, Senior Vice President - Human Resources

 Accepted and Agreed: 
  

									
	By:	 	 /s/ Lex Gemas
	 		 	Date: October 9, 2013

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00222-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00222-of-00352.parquet"}]]